In today’s recent session, 0.47 million shares of the Cognition Therapeutics Inc (NASDAQ:CGTX) have been traded, and its beta is 1.32. Most recently the company’s share price was $0.45, and it changed around $0.01 or 1.67% from the last close, which brings the market valuation of the company to $18.76M. CGTX at last check was trading at a discount to its 52-week high of $2.95, offering almost -555.56% off that amount. The share price’s 52-week low was $0.34, which indicates that the recent value has risen by an impressive 24.44% since then. We note from Cognition Therapeutics Inc’s average daily trading volume that its 10-day average is 0.35 million shares, with the 3-month average coming to 520.63K.
Cognition Therapeutics Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.33. If we narrow it down even further, the data shows that 0 out of 5 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 1 recommended CGTX as a Hold, whereas 3 deemed it a Buy, and 0 rated it as Underweight. Cognition Therapeutics Inc is expected to report earnings per share of -0.21 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Cognition Therapeutics Inc (NASDAQ:CGTX) trade information
Instantly CGTX has been showing a green trend so far today with a performance of 1.67% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.5408 on recent trading dayincreased the stock’s daily price by 16.79%. The company’s shares are currently down -75.60% year-to-date, but still down -15.95% over the last five days. On the other hand, Cognition Therapeutics Inc (NASDAQ:CGTX) is -6.44% down in the 30-day period. We can see from the shorts that 0.82 million shares have been sold at a short interest cover period of 1.07 day(s).
Cognition Therapeutics Inc (CGTX) estimates and forecasts
Cognition Therapeutics Inc share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -82.77 percent over the past six months and at a -11.63% annual growth rate that is well below the industry average of 18.10%.
Forecasts for the next quarter put sales growth at �.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -21.09%.
CGTX Dividends
Cognition Therapeutics Inc’s next quarterly earnings report is expected to be released in December.
Cognition Therapeutics Inc (NASDAQ:CGTX)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 0.54% of Cognition Therapeutics Inc shares, and 24.53% of them are in the hands of institutional investors. The stock currently has a share float of 24.67%. Cognition Therapeutics Inc stock is held by 41.0 institutions, with VANGUARD GROUP INC being the largest institutional investor. By 2024-06-30, it held 3.4016% of the shares, which is about 1.15 million shares worth $1.9 million.
AWM INVESTMENT COMPANY, INC., with 1.9268% or 0.65 million shares worth $1.08 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund were the top two Mutual Funds as of Jun 30, 2024. The former held 914.9 shares worth $0.41 million, making up 2.20% of all outstanding shares. On the other hand, Vanguard Extended Market Index Fund held roughly 200.58 shares worth around $90700.0, which represents about 0.48% of the total shares outstanding.
